scholarly journals Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial

BMJ ◽  
2009 ◽  
Vol 339 (nov09 1) ◽  
pp. b4324-b4324 ◽  
Author(s):  
S. S Lund ◽  
L. Tarnow ◽  
M. Frandsen ◽  
B. B Nielsen ◽  
B. V Hansen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Obese Patients ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial ◽  
Insulin Secretagogue

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

The Lancet ◽  
2015 ◽  
Vol 385 (9982) ◽  
pp. 2067-2076 ◽  
Author(s):  
Faiez Zannad ◽  
Christopher P Cannon ◽  
William C Cushman ◽  
George L Bakris ◽  
Venu Menon ◽  
...  
Keyword(s):  
Heart Failure ◽  
Type 2 Diabetes ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial

scholarly journals 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

The Lancet ◽  
2017 ◽  
Vol 389 (10077) ◽  
pp. 1399-1409 ◽  
Author(s):  
Carel W le Roux ◽  
Arne Astrup ◽  
Ken Fujioka ◽  
Frank Greenway ◽  
David C W Lau ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Risk Reduction ◽  
Weight Management ◽  
Diabetes Risk ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial

scholarly journals Metabolic Effects of Replacing Sucrose by Isomaltulose in Subjects With Type 2 Diabetes: A randomized double-blind trial

Diabetes Care ◽  
2012 ◽  
Vol 35 (6) ◽  
pp. 1249-1251 ◽  
Author(s):  
S. Brunner ◽  
I. Holub ◽  
S. Theis ◽  
A. Gostner ◽  
R. Melcher ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Metabolic Effects ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial
Sign in / Sign up

Export Citation Format

Share Document